Cold-stored platelets: A product with function optimized for hemorrhage control

K. M. Reddoch-Cardenas*, J. A. Bynum, M. A. Meledeo, P. M. Nair, X. Wu, D. N. Darlington, A. K. Ramasubramanian, A. P. Cap

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


Early administration of blood products following severe trauma is pivotal for establishing hemostasis and achieving successful outcomes. Platelet transfusions, in particular, provide rapid control of hemostasis and help to restore platelet dysfunction induced by trauma. In the U.S. platelets used for therapeutic purposes are stored at room temperature with a limited shelf life of 5-7 days. Issues with room temperature storage of platelets, including an increased risk of bacterial growth and a decline in platelet hemostatic function, have led to a resurgence in interest in cold-stored platelets for therapeutic transfusion. This review presents the current state of cold-stored platelets and cold-stored whole blood as treatment for actively bleeding patients. Usage of cold stored platelets in alternative areas, such as in the field of regenerative medicine, is also discussed.

Original languageEnglish
Pages (from-to)16-22
Number of pages7
JournalTransfusion and Apheresis Science
Issue number1
StatePublished - Feb 2019
Externally publishedYes


  • Cold stored platelets
  • Cold stored whole blood
  • Platelet transfusion
  • Therapeutic transfusion


Dive into the research topics of 'Cold-stored platelets: A product with function optimized for hemorrhage control'. Together they form a unique fingerprint.

Cite this